SCHEMBL6366133

SCHEMBL6366133

Cc1cc(Br)cc(C(=O)N2CCCC2)c1NCC1=NCCN1

nearest known ligand 0.58

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 15/20 0.58
▸ ADRA1B P35368 14/20 0.58
▸ ADRA1D P25100 12/20 0.57
▸ HTR1D P28221 2/20 0.44
▸ HTR1B P28222 2/20 0.44
▸ ADRA2B P18089 1/20 0.40
▸ ADRA2C P18825 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6365969 0.81 ADRA1A (0.72) ADRA1AADRA1BADRA1D
SCHEMBL6371379 0.77 ADRA1A (0.72) ADRA1AADRA1BADRA1DADRA2BADRA2C
SCHEMBL6367118 0.73 ADRA1A (1.00) ADRA1AADRA1BADRA1D
SCHEMBL6366241 0.73 ADRA1A (1.00) ADRA1AADRA1BADRA1D
SCHEMBL6366979 0.72 ADRA1A (0.72) ADRA1AADRA1BADRA1DADRA2BADRA2C
SCHEMBL6367199 0.72 ADRA1A (0.72) ADRA1AADRA1BADRA1DADRA2BADRA2C
SCHEMBL6366018 0.72 ADRA1A (0.69) ADRA1AADRA1BADRA1DADRA2BADRA2C
Fumaric Acid SCHEMBL6425260 0.69 ADRA1A (0.88) ADRA1AADRA1BADRA1D
Fumaric Acid SCHEMBL6425264 0.69 ADRA1A (0.88) ADRA1AADRA1BADRA1D
SCHEMBL6372476 0.66 GAA (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884801-B1 Imidazoline derivatives as alpha-1A adrenoceptor ligands SMITHKLINE BEECHAM CORPORATION (US) 2005-04-26 — — US disclosed
EP-1175406-A1 IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2002-01-30 — — EP disclosed
WO-2000066563-A1 IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2000-11-09 — — WO disclosed
Send feedback